Veradace Capital Management’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.1M Buy
133,607
+105,274
+372% +$1.35M 1.58% 13
2026
Q1
$235K Buy
+28,333
New +$256K 0.21% 20

Other funds holding CYRX

Veradace Capital Management's CYRX Position: Q2 2026 in Review

Veradace Capital Management increased its CryoPort (CYRX) stake by 372% in Q2 2026, buying an estimated $1.35M and bringing the position to 133,607 shares worth $2.1M. The position accounts for 1.58% of the portfolio, ranked #13.

Veradace Capital Management first reported a position in CYRX in Q1 2026 and has held it in 2 quarters since. 184 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

  • Veradace Capital Management held 133,607 shares of CryoPort worth $2.1M as of Q2 2026.
  • Veradace Capital Management bought 105,274 CryoPort shares in Q2 2026, an estimated $1.35M.
  • CryoPort made up 1.58% of Veradace Capital Management's portfolio in Q2 2026, its #13 holding.
  • Veradace Capital Management first reported a position in CryoPort in Q1 2026 and has held it in 2 quarters since.
  • 184 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on Veradace Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.